138 related articles for article (PubMed ID: 37451428)
21. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
22. Lifestyle factors associated with sex differences in Kaposi sarcoma incidence among adult black South Africans: A case-control study.
Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
Cancer Epidemiol; 2022 Jun; 78():102158. PubMed ID: 35421713
[TBL] [Abstract][Full Text] [Related]
23. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
[TBL] [Abstract][Full Text] [Related]
24. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
[TBL] [Abstract][Full Text] [Related]
25. Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.
Cancer Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord
Clin Infect Dis; 2016 Nov; 63(10):1373-1379. PubMed ID: 27535953
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
27. Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men.
Luu HN; Amirian ES; Chiao EY; Scheurer ME
Cancer Med; 2014 Dec; 3(6):1635-43. PubMed ID: 25139791
[TBL] [Abstract][Full Text] [Related]
28. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
Jones JL; Hanson DL; Dworkin MS; Jaffe HW
J Acquir Immune Defic Syndr; 2000 Jul; 24(3):270-4. PubMed ID: 10969352
[TBL] [Abstract][Full Text] [Related]
29. Risk of Nonkeratinocyte Skin Cancers in People Living with HIV during the Era of Antiretroviral Therapy.
Luu YT; Luo Q; Horner MJ; Shiels M; Engels EA; Sargen MR
J Invest Dermatol; 2023 Apr; 143(4):588-595.e3. PubMed ID: 36216206
[TBL] [Abstract][Full Text] [Related]
30. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma: clinico-pathological analysis of human immunodeficiency virus (HIV) and non-HIV associated cases.
Hong A; Lee CS
Pathol Oncol Res; 2002; 8(1):31-5. PubMed ID: 11994760
[TBL] [Abstract][Full Text] [Related]
32. Kaposi sarcoma in people living with HIV: incidence and associated factors in a French cohort between 2010 and 2015.
Poizot-Martin I; Lions C; Cheret A; Rey D; Duvivier C; Jacomet C; Allavena C; Huleux T; Bani-Sadr F; Obry-Roguet V; Makinson A;
AIDS; 2020 Mar; 34(4):569-577. PubMed ID: 31764070
[TBL] [Abstract][Full Text] [Related]
33. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes for children and adolescents with Kaposi sarcoma.
Silverstein A; Kamiyango W; Villiera J; Peckham-Gregory EC; McAtee CL; Scheurer ME; Cox CM; Kovarik CL; Campbell LR; Allen CE; Mehta PS; Kazembe PN; Ozuah NW; El-Mallawany NK
HIV Med; 2022 Feb; 23(2):197-203. PubMed ID: 34634187
[TBL] [Abstract][Full Text] [Related]
35. Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
Kowalkowski MA; Kramer JR; Richardson PR; Suteria I; Chiao EY
Clin Infect Dis; 2015 May; 60(9):1405-14. PubMed ID: 25586682
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy.
Palmieri C; Dhillon T; Thirlwell C; Newsom-Davis T; Young AM; Nelson M; Gazzard BG; Bower M
HIV Med; 2006 Jul; 7(5):291-3. PubMed ID: 16945073
[TBL] [Abstract][Full Text] [Related]
37. Age and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study.
Ruffieux Y; Muchengeti M; Olago V; Dhokotera T; Bohlius J; Egger M; Rohner E
Clin Infect Dis; 2023 Apr; 76(8):1440-1448. PubMed ID: 36461916
[TBL] [Abstract][Full Text] [Related]
38. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
39. Cancer in patients with and without HIV infection in the national cancer registry of Rwanda.
Hagenimana M; Kodan AE; George N; Businge L; Francois U; Nsanzimana S; Riedel DJ
AIDS; 2023 Jan; 37(1):83-90. PubMed ID: 36172844
[TBL] [Abstract][Full Text] [Related]
40. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
Phipps W; Ssewankambo F; Nguyen H; Saracino M; Wald A; Corey L; Orem J; Kambugu A; Casper C
PLoS One; 2010 Nov; 5(11):e13936. PubMed ID: 21103057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
